STARK Industries awarded a global license by NASA JPL – Caltech to manufacture, assemble, distribute, sell, and service NASA JPL's – VITAL Ventilator design in the fight against COVID-19
Lineus Medical has completed the first $1.25M tranche of a Series B funding round. The company was founded in 2015 and has raised a total of $4.7M over the past 5 years.
Investors are excited about biotechnology stocks in the time of the novel coronavirus. The Wall Street Journal reports that small and medium biotech stocks are near record highs, with a 60% resurgence in value since March.
Lineus Medical continues to expand the patent protection of its flagship product, SafeBreak Vascular, a break-away medical device technology that helps protect IV lines.
Former NASA Scholar/Scientist Leads Team in Developing New Wastewater Processing Plants in The Netherlands Using Algae to Make Plant-based Meats and Sustainable Agricultural Containers With Zero Carbon Footprint While Reducing Global Warming by...
With the release of version V2.24.1.065 Quality Essentials Suite introduces a set of advanced features designed to enable greater collaboration internally and externally for the quality control department.
Race and Coronavirus, a new media platform featuring a weekly newsletter and podcast by veteran Bay Area journalists Levi Sumagaysay and Pati Navalta, has partnered with Bay City News Foundation.
20Lighter, LLC., a leading consumer health company primarily focused on obesity and cardiometabolic disease with innovative comprehensive programs, today announced that the United States Patent and Trademark Office has issued US Patent 10,638,786,...
Retired NASA Scholar/Scientist Tapped to Lead Team in Developing and Testing New Delivery System with Antagonists that Kill Viruses Joins in the Fight Against COVID-19 and the Global Pandemic
Scientific image and data analysis software provider ViQi, Inc. welcomes bio-image informatics and machine learning pioneer Ilya Goldberg, Ph.D. as Chief Science Officer.
PermianMuseum.com finished its Spring fossil egg hunt and released photos of its 2020 Fossilized Egg Collection. The Permian period was from 300 - 252 Mya.
Networking solutions enabling employee teams with unique work connectivity requirements to maintain customer service and data security while working from home
Sargas Remote Monitoring technology, with FDA's latest guidance helps monitor COVID-19 positive patients' body temperature, oxygen saturations, blood pressures, and heart rates while on home isolation.
Company is one of 30 selected for prestigious competition. During BIO Digital Week, attendees can watch timely, on-demand pitches and meet with ExpressCells via BIO's One-on-One Partnering.
Molecular Depot introduces: Human Hemoglobin for Interference Testing. Highly concentrated solution of human hemoglobin (200 mg/mL) provided with the corresponding diluent.
Molecular Depot introduces Free Bilirubin for Interference Testing. Highly concentrated solution of free bilirubin(20 mg/mL) provided with the corresponding diluent.
Biotech Support Group reports on two journal articles describing the efficiency and simplicity of their hemoglobin depletion products for proteomic analysis of serum, and the seroprevalence of virus antibodies.
STARK Industries awarded a global license by NASA JPL – Caltech to manufacture, assemble, distribute, sell, and service NASA JPL's – VITAL Ventilator design in the fight against COVID-19
Big Red has been awarded contracts to Singapore's leading campus of higher learning, to apply its surface protection product BRShield to all high touch surfaces in the campus.
Lineus Medical has completed the first $1.25M tranche of a Series B funding round. The company was founded in 2015 and has raised a total of $4.7M over the past 5 years.
Jubilant grants an exclusive license to Lengo Therapeutics, a biopharma company focused on the discovery and development of novel treatments targeting driver mutations in oncology.
Zynfusion is pleased to announce the appointment of Mark Terrill as its new CEO, replacing Amit Mehta who is assuming the position of Chairman of the Board after 2 years as CEO.
Investors are excited about biotechnology stocks in the time of the novel coronavirus. The Wall Street Journal reports that small and medium biotech stocks are near record highs, with a 60% resurgence in value since March.
DPI Research has recently published a comprehensive analysis titled "Worldwide Diabetes Disposable Insulin Delivery Pen Market Prospect, Share, Development, Growth and Demand Forecast to 2026" to its intensifying repository.
The coronavirus or COVID-19 pandemic is claiming many lives, impacting the health of close to 5 million people with 324,000 deaths worldwide. As an "unknown disease with many faces", it has pushed the scientific community into a frenzy to find cure.
Lineus Medical continues to expand the patent protection of its flagship product, SafeBreak Vascular, a break-away medical device technology that helps protect IV lines.
Molecular Depot introduces Biotin anti Human IgM polyclonal antibody is a high quality biotinylated anti-human IgM antibody produced in goat. This antibody is specific to human IgM antibodies and does not react with other human antibodies.
Molecular Depot is introducing: Unique donor serum sample with high levels (> 500 ng/mL) of Human Anti-Mouse Antibodies (HAMA). HAMA titer has been established with a validated ELISA method.
Former NASA Scholar/Scientist Leads Team in Developing New Wastewater Processing Plants in The Netherlands Using Algae to Make Plant-based Meats and Sustainable Agricultural Containers With Zero Carbon Footprint While Reducing Global Warming by...
. AbVision, Inc., an innovative biopharmaceutical company, announced today that the Company has developed a biosuperior anti-CD47 therapeutic antibody (AVI-105), powered by its SpeedyAb™ technology platform of therapeutic antibody.
With the release of version V2.24.1.065 Quality Essentials Suite introduces a set of advanced features designed to enable greater collaboration internally and externally for the quality control department.
With multi-billion funding initiatives publicly disclosed by various government agencies, and private investors, various leading pharma companies are developing novel drug candidates for the treatment of patients infected with COVID-19
Race and Coronavirus, a new media platform featuring a weekly newsletter and podcast by veteran Bay Area journalists Levi Sumagaysay and Pati Navalta, has partnered with Bay City News Foundation.
